[Summary] Dedicated to the R&D, production, and sales of testing instruments and
Beijing Succeeder Technology Inc. was established in 2003. Since its inception, the company has been dedicated to the R&D, production, and sales of testing instruments and reagents in the field of thrombus and hemostasis in vitro diagnostics, providing medical institutions with automated testing instruments and supporting reagents and consumables for coagulation, hemorheology, erythrocyte sedimentation rate and hematocrit, and platelet aggregation. It is a leading domestic manufacturer in the field of thrombus and hemostasis in vitro diagnostics. The company's thrombus and hemostasis in vitro diagnostic products are mainly applied to the prevention, screening, diagnosis, and monitoring of thrombotic diseases such as stroke, coronary heart disease, and venous thromboembolism, as well as hemorrhagic diseases. Succeeder provides employees with a good platform for personal development: competitive compensation, rich employee benefits, social insurance and housing fund paid in accordance with national regulations, paid annual leave and statutory holidays, and a canteen and dormitory. Company Name: Beijing Succeeder Technology Inc. Contact Phone: ***********: *
What does Beijing Succeeder Technology Inc. require? Who is Succeeder hiring? Succeeder recruitment: 销售类占比最多占39.6%，其次是客户服务类占14.3%. What education can get in at Succeeder? 大专占比最多占51.6%，其次是本科占47.3%. High education required at Succeeder? 硕士占1.1%. Work experience required at Succeeder? 1-3年占比最多占52.7%，其次是不限占24.2%. Where are the job locations at Succeeder? 北京占比最多占53.8%，其次是南京占4.4%. Based on job postings from the past year, for reference only.
Provided by
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows
Jobui does not provide an APP. Please follow our WeChat official account.
